Literature DB >> 409283

X-linked Hunter syndrome: the heterozygous phenotype in cell culture.

B R Migeon, J A Sprenkle, I Liebaers, J F Scott, E F Neufeld.   

Abstract

Fibroblast cultures derived from the skin of three Hunter heterozygotes have been examined for iduronate sulfatase deficiency primarily by measurement of [35S]-mucopolysaccharide accumulation in the presence and absence of Hunter corrective factor. For each heterozygote, two populations of clones were observed: normal and enzyme deficient, as predicted by the Lyon hypothesis. However, the phenotype of the uncloned cultures was usually normal, presumably because of cross-correction, even after storage in liquid N2. Mixing experiments indicate that the presence of a majority of cells with the Hunter phenotype may be obscured as the result of correction by the minority population of normal cells in the mixture. Variability in the ability to cross-correct was also demonstrated. The unpredictable behavior of uncloned cultures make them unsuitable for diagnosing the Hunter carrier state.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 409283      PMCID: PMC1685417     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Sex chromatin and gene action in the mammalian X-chromosome.

Authors:  M F LYON
Journal:  Am J Hum Genet       Date:  1962-06       Impact factor: 11.025

2.  Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts.

Authors:  J C Fratantoni; C W Hall; E F Neufeld
Journal:  Science       Date:  1968-11-01       Impact factor: 47.728

3.  Demonstration of the heterozygous state in Hunter's syndrome.

Authors:  C W Booth; H L Nadler
Journal:  Pediatrics       Date:  1974-03       Impact factor: 7.124

4.  In vitro selection for the Hunter gene.

Authors:  C W Booth; H L Nadler
Journal:  N Engl J Med       Date:  1973-03-22       Impact factor: 91.245

5.  Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome.

Authors:  M R Capobianchi; G Romeo
Journal:  Experientia       Date:  1976-04-15

6.  Iduronate sulfatase in amniotic fluid: an aid in the prenatal diagnosis of the hunter syndrome.

Authors:  I Liebaers; P Di Natale; E F Neufeld
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

7.  The Hunter corrective factor. Purification and preliminary characterization.

Authors:  M Cantz; A Chrambach; G Bach; E F Neufeld
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

8.  X-linked hypoxanthine-guanine phosphoribosyl transferase deficiency: heterozygote has two clonal populations.

Authors:  B R Migeon; V M Der Kaloustian; W L Nyhan; W J Yough; B Childs
Journal:  Science       Date:  1968-04-26       Impact factor: 47.728

9.  The Hunter syndrome in females: is there an autosomal recessive form of iduronate sulfatase deficiency?

Authors:  E F Neufeld; I Liebaers; C J Epstein; S Yatziv; A Milunsky; B R Migeon
Journal:  Am J Hum Genet       Date:  1977-09       Impact factor: 11.025

10.  Hurler's syndrome: a genetic study of clones in cell culture with particular reference to the Lyon hypothesis.

Authors:  B S Danes; A G Bearn
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Replacement therapy in the mucopolysaccharidoses.

Authors:  M F Dean
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

2.  Iduronate sulfatase analysis of hair roots for identification of Hunter syndrome heterozygotes.

Authors:  T Yutaka; A L Fluharty; R L Stevens; H Kihara
Journal:  Am J Hum Genet       Date:  1978-11       Impact factor: 11.025

3.  Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.

Authors:  K M Timms; F J Edwards; J W Belmont; J R Yates; R A Gibbs
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

4.  Germline and somatic mosaicism in a female carrier of Hunter disease.

Authors:  R Froissart; I Maire; V Bonnet; T Levade; D Bozon
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

5.  Expression of genes from the human active and inactive X chromosomes.

Authors:  C J Brown; L Carrel; H F Willard
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

6.  Biochemical diagnosis of mucopolysaccharidoses: experience of 297 diagnoses in a 15-year period (1977-1991).

Authors:  P Di Natale; T Annella; A Daniele; T De Luca; E Morabito; R Pallini; P Rosario; G Spagnuolo
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Reliability of the Tønnesen technique for the identification of Hunter carriers.

Authors:  L Petruschka; G Machill; M Wehnert; G Seidlitz; A Knapp
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  The use of fructose 1-phosphate to detect Hunter heterozygotes in fibroblast cultures from high-risk carriers.

Authors:  T Tønnesen
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  X inactivation of the FMR1 fragile X mental retardation gene.

Authors:  C U Kirchgessner; S T Warren; H F Willard
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

10.  A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblasts from patients and carriers.

Authors:  G E Jones; J A Witkowski
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.